1. Home
  2. ZKIN vs RNXT Comparison

ZKIN vs RNXT Comparison

Compare ZKIN & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ZK International Group Co. Ltd

ZKIN

ZK International Group Co. Ltd

SELL

Current Price

$1.70

Market Cap

84.8M

Sector

Industrials

ML Signal

SELL

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$1.19

Market Cap

79.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZKIN
RNXT
Founded
2015
2012
Country
China
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.8M
79.4M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
ZKIN
RNXT
Price
$1.70
$1.19
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $7.13
AVG Volume (30 Days)
54.8K
★ 551.1K
Earning Date
08-21-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 20.00
EPS
★ N/A
N/A
Revenue
N/A
★ $1,123,000.00
Revenue This Year
N/A
$244.84
Revenue Next Year
N/A
$195.26
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 2511.63
52 Week Low
$1.00
$0.70
52 Week High
$3.11
$2.59

Technical Indicators

Market Signals
Indicator
ZKIN
RNXT
Relative Strength Index (RSI) 54.92 35.72
Support Level $1.30 $0.83
Resistance Level $1.94 $1.28
Average True Range (ATR) 0.13 0.11
MACD -0.03 -0.05
Stochastic Oscillator 4.81 20.54

Price Performance

Historical Comparison
ZKIN
RNXT

About ZKIN ZK International Group Co. Ltd

ZK International Group Co Ltd is engaged in the manufacture and marketing of metal pipes. The company is specialized in producing double-press thin-walled stainless steel tubes and fittings, carbon steel tubes and fittings, single-press tubes and fittings, and stainless-steel strips. The products are used in restaurants, hotels, hospitals, firefighting, food, beverage, ships, engines, industrial seawater desalination and systems of direct-drinking water, cold /hot water supply, city water supply, and gas of large/middle scale construction projects.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: